11 – 20 of 26
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Integration across biophysical scales identifies molecular and cellular correlates of person-to-person variability in human brain connectivity
(
- Contribution to journal › Article
-
Mark
Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Comparison of Group-Level and Individualized Brain Regions for Measuring Change in Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
(
- Contribution to journal › Article
-
Mark
Data-driven neuropathological staging and subtyping of TDP-43 proteinopathies
(
- Contribution to journal › Article
-
Mark
Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum
(
- Contribution to journal › Article
-
Mark
The molecular genetic landscape of human brain size variation
(
- Contribution to journal › Article
-
Mark
Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA : Methodological limitations and convergent results
(
- Contribution to journal › Scientific review
-
Mark
Connectome-based modelling of neurodegenerative diseases : towards precision medicine and mechanistic insight
(
- Contribution to journal › Scientific review
-
Mark
Gray matter hypoperfusion is a late pathological event in the course of Alzheimer's disease
2023) In Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 43(4). p.565-580(
- Contribution to journal › Article
- 2022
-
Mark
Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease
(
- Contribution to journal › Article